Blue Water Life Science Advisors, LP 13F holdings, Q2 2026
Holdings as of June 30, 2026 · filings on SEC EDGAR · this is the latest filing on record
Blue Water Life Science Advisors, LP disclosed 9 US equity positions worth $158.8m in its Q2 2026 13F filing. The largest position was CDNA at 21.4% of the reported book, followed by TXG and PSNL. Against the Q1 2026 filing, it opened 0 new positions, added to 3 and reduced 4 among the top 9 holdings.
What did Blue Water Life Science Advisors, LP own in Q2 2026? Top 9 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q1 2026 |
|---|---|---|---|---|---|---|---|
| 1 | CDNA CAREDX INC | Healthcare | 21.4% | $33.9m | 1,190,000 | 27% | added |
| 2 | TXG 10X GENOMICS INC | Healthcare | 15.5% | $24.6m | 642,000 | -41% | reduced |
| 3 | PSNL PERSONALIS INC | Healthcare | 14.1% | $22.5m | 1,676,300 | 0% | held |
| 4 | ADPT ADAPTIVE BIOTECHNOLOGIES COR | Healthcare | 13.6% | $21.7m | 1,010,145 | 0% | held |
| 5 | GH GUARDANT HEALTH INC | Healthcare | 10.8% | $17.2m | 114,747 | -53% | reduced |
| 6 | QTRX QUANTERIX CORP | Healthcare | 9.5% | $15.0m | 3,474,202 | 62% | added |
| 7 | NTRA NATERA INC | Healthcare | 5.9% | $9.4m | 34,494 | -23% | reduced |
| 8 | BLLN BILLIONTOONE INC | 5.3% | $8.4m | 70,000 | 250% | added | |
| 9 | TEM TEMPUS AI INC | Healthcare | 3.8% | $6.1m | 105,412 | -33% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.